↓ Skip to main content

Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem® 8 mg)

Overview of attention for article published in Folia Pharmacologica Japonica, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
11 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
14 Mendeley